Series of N-of-1 trials to detect the effects of ultra-diluted delta SARS-CoV-2 spike protein in expression of interferons in healthy human volunteers

Satadal Das; Subhasish Ganguly; Debasmita Chatterjee; Krishnendu Paira; Banhisikha Singh; Shyamal Kumar Mukherjee; Sangita Saha; Soumya Bhattacharyya; Pulakendu Bhattacharya; Priyanka Sen; Subhranil Saha

doi:10.17632/bvt6m6bwzx.1

Series of N-of-1 trials to detect the effects of ultra-diluted delta SARS-CoV-2 spike protein in expression of interferons in healthy human volunteers

Mendeley Data 2026 Dataset Open access

Read full text

Authors: Satadal Das, Subhasish Ganguly, Debasmita Chatterjee, Krishnendu Paira, Banhisikha Singh, Shyamal Kumar Mukherjee, Sangita Saha, Soumya Bhattacharyya, Pulakendu Bhattacharya, Priyanka Sen, Subhranil Saha

DOI: 10.17632/bvt6m6bwzx.1

Cited by: 0

Abstract

This paper reports a series of double-blind, placebo-controlled N-of-1 trials assessing iAttos, an ultra-diluted delta SARS-CoV-2 spike protein homeopathic preparation, for immunomodulatory effects on nine cytokines (IFNs α/β/γ, IL-1/6/8/10, TGF-β1/3) in 10 healthy volunteers using multiple crossover cycles with intensive longitudinal sampling.

Publication details

Journal / source: Mendeley Data
Publication date: 7 January 2026
Document type: Dataset